1. Effect of ruxolitinib cream on achievement of VASI50 by body region: Week 52 pooled analysis of the TRuE-V phase 3 studies. (18th January 2023) Authors: Passeron, Thierry; Harris, John E; Pandya, Amit G; Seneschal, Julien; Grimes, Pearl; Kornacki, Deanna; Wang, Mingyue; Butler, Kathleen; Ezzedine, Khaled; Rosmarin, David Journal: British journal of dermatology Issue: Volume 188(2023)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Melasma: clinical diagnosis and management options. (9th March 2015) Authors: Rodrigues, Michelle; Pandya, Amit G Journal: Australasian journal of dermatology Issue: Volume 56:Number 3(2015:Aug.) Page Start: 151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Randomised, controlled, double‐blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma. (28th February 2020) Authors: Shihab, Nahla; Prihartono, Joedo; Tovar‐Garza, Andrea; Agustin, Triana; Legiawati, Lili; Pandya, Amit G Journal: Australasian journal of dermatology Issue: Volume 61:Number 3(2020) Page Start: 237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial. Issue 10244 (11th July 2020) Authors: Rosmarin, David; Pandya, Amit G; Lebwohl, Mark; Grimes, Pearl; Hamzavi, Iltefat; Gottlieb, Alice B; Butler, Kathleen; Kuo, Fiona; Sun, Kang; Ji, Tao; Howell, Michael D; Harris, John E Journal: Lancet Issue: Volume 396:Issue 10244(2020) Page Start: 110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗